Page 526 - Hall et al (2015) Principles of Critical Care-McGraw-Hill

6 References

refractory left ventricular failure and/or recurrent ventricular 150. Berger PB, Holmes DR Jr., Stebbins AL, Bates ER, Califf RM,
tachycardia. Am J Med. 1975;58:183-191. Topol EJ. Impact of an aggressive invasive catheterization
145. Bates ER, Stomel RJ, Hochman JS, Ohman EM. The use of and revascularization strategy on mortality in patients with
intraaortic balloon counterpulsation as an adjunct to reperfu- cardiogenic shock in the Global Utilization of Streptokinase
sion therapy in cardiogenic shock. Int J Cardiol. 1998;65(suppl 1): and Tissue Plasminogen Activator for Occluded Coronary
S37-S42. Arteries (GUSTO-I) trial. An observational study. Circulation.
146. Gruppo Italiano per lo Studio Della Streptochinasi Nell’Infarto 1997;96:122-127.
Miocardico (GISSI). Effectiveness of intravenous thrombolytic 151. Rogers WJ, Canto JG, Lambrew CT, et al. Temporal trends
treatment in acute myocardial infarction. Lancet. 1986;2:397-402. in the treatment of over 1.5 million patients with myocardial
147. Sanborn TA, Sleeper LA, Bates ER, et al. Impact of thromboly- infarction in the US from 1990 through 1999: the National
Registry of Myocardial Infarction 1, 2 and 3. J Am Coll Cardiol.
sis, intra-aortic balloon pump counterpulsation, and their com- 2000;36:2056-2063.
bination in cardiogenic shock complicating acute myocardial
infarction: a report from the SHOCK Trial Registry. SHould we 152. Hochman JS, Sleeper LA, Webb JG, et al. Early revasculariza-
emergently revascularize Occluded Coronaries for cardiogenic tion in acute myocardial infarction complicated by cardiogenic
shocK? J Am Coll Cardiol. 2000;36:1123-1129. shock. N Engl J Med. 1999;341:625-634.
148. Becker RC. Hemodynamic, mechanical, and metabolic deter- 153. Hochman JS, Sleeper LA, White HD, et al. One-year survival
minants of thrombolytic efficacy: a theoretic framework for following early revascularization for cardiogenic shock. JAMA.
assessing the limitations of thrombolysis in patients with car- 2001;285:190-192.
diogenic shock. Am Heart J. 1993;125:919-929. 154. Urban P, Stauffer JC, Bleed D, et al. A randomized evaluation of
149. Garber PJ, Mathieson AL, Ducas J, Patton JN, Geddes JS, early revascularization to treat shock complicating acute myo-
Prewitt RM. Thrombolytic therapy in cardiogenic shock: effect cardial infarction. The (Swiss) Multicenter Trial of Angioplasty
of increased aortic pressure and rapid tPA administration. Can for Shock-(S)MASH. Eur Heart J. 1999;20:1030-1038.
J Cardiol. 1995;11:30-36.

Section03-O-ref.indd 6 1/20/2015 7:10:24 AM